UBS Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $143K | Sell |
|
|||||
|
2025
Q2 | $200K | Buy |
|
|||||
|
2025
Q1 | $55.9K | Buy |
|
|||||
|
2024
Q4 | $63.6K | Sell |
|
|||||
|
2024
Q3 | $56.1K | Buy |
|
|||||
|
2024
Q2 | $73.2K | Sell |
|
|||||
|
2024
Q1 | $176K | Sell |
|
|||||
|
2023
Q4 | $262K | Buy |
|
|||||
|
2023
Q3 | $182K | Sell |
|
|||||
|
2023
Q2 | $293K | Buy |
|
|||||
|
2023
Q1 | $207K | Buy |
|
|||||
|
2022
Q4 | $68.8K | Hold |
|
|||||
|
2022
Q3 | $54K | Sell |
|
|||||
|
2022
Q2 | $71K | Buy |
|
|||||
|
2022
Q1 | $126K | Sell |
|
|||||
|
2021
Q4 | $1.24M | Buy |
|
|||||
|
2021
Q3 | $854K | Buy |
|
|||||
|
2021
Q2 | $315K | Sell |
|
|||||
|
2021
Q1 | $640K | Buy |
|
|||||
|
2020
Q4 | $282K | Buy |
|
|||||
|
2020
Q3 | $325K | Hold |
|
|||||
|
2020
Q2 | $529K | Sell |
|
|||||
|
2020
Q1 | $439K | Sell |
|
|||||
|
2019
Q4 | $933K | Buy |
|
|||||
|
2019
Q3 | $409K | Buy |
|
|||||
|
2019
Q2 | $326K | Buy |
|
|||||
|
2019
Q1 | $235K | Sell |
|
|||||
|
2018
Q4 | $175K | Buy |
|
|||||
|
2018
Q3 | $236K | Buy |
|
|||||
|
2018
Q2 | $275K | Buy |
|
|||||
|
2018
Q1 | $52K | Buy |
|